Federal budget issues
health care access and affordability, workforce reauthorization, veteran's healthcare, Medicare physician payment reform, physician workforce
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Duration: May 1, 2018
to
present
General Issues: Budget/Appropriations , Health Issues , Medicare/Medicaid , Education
Spending: about $1,890,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Raissa Downs Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
Jennifer Young Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance
Michelle Easton Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
Elizabeth Murray Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
Charlotte Ivancic Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner
Pamela Smith Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun
Emily Murry Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price
Kimberly Brandt Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance
Margaret Joseph CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte.
Peter Fise Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform
Laura Friedel Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on April 16.
Original Filing: 301550714.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
health care access and affordability, workforce reauthorization, veteran's healthcare, Medicare physician payment reform, physician workforce
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Jan. 17.
Original Filing: 301526540.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
health care access and affordability, workforce reauthorization, veteran's healthcare, Medicare physician payment reform, physician workforce
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Oct. 17, 2023.
Original Filing: 301502898.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
health care access and affordability, workforce reauthorization, veteran's healthcare, Medicare physician payment reform, physician workforce
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on July 17, 2023.
Original Filing: 301477961.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
health care access and affordability, workforce reauthorization, veteran's healthcare, Medicare physician payment reform, physician workforce
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on April 19, 2023.
Original Filing: 301459166.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
health care access and affordability, pre-existing conditions, workforce reauthorization, veteran's healthcare, Medicare physician payment reform, physician workforce
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438859.xml
Lobbying Issues
H.R.2617, Consolidated Appropriations Act, 2023
ARPA-H, reconciliation
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Inflation Reduction Act
H.R.2617, Consolidated Appropriations Act, 2023
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA, Veterans' Health Care, Medicare physician payment reform, physician workforce, Provider Relief Fund, vaccines and pandemic response, surprise medical billing implementation, MedPAC nomination process
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach, Graduate Medical Education, osteopathic manipulative treatment, opioid alternatives, MedPAC, Resident Physician Shortage
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413641.xml
Lobbying Issues
H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
ARPA-H, reconciliation
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Inflation Reduction Act
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA, Veterans' Health Care, Medicare physician payment reform, physician workforce, Provider Relief Fund, vaccines and pandemic response, surprise medical billing implementation, MedPAC nomination process
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach, Graduate Medical Education, osteopathic manipulative treatment, opioid alternatives, MedPAC, Resident Physician Shortage
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on July 19, 2022.
Original Filing: 301386663.xml
Lobbying Issues
H.R. 2471, Consolidated Appropriations Act 2022
ARPA-H, reconciliation
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376, the Build Back Better Act
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA, Veterans' Health Care, Medicare physician payment reform, physician workforce, Provider Relief Fund, vaccines and pandemic response, surprise medical billing implementation, MedPAC nomination process
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach, Graduate Medical Education, osteopathic manipulative treatment, opioid alternatives, MedPAC, Resident Physician Shortage
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on April 14, 2022.
Original Filing: 301355923.xml
Lobbying Issues
ARPA-H, reconciliation
H.R. 2471, Consolidated Appropriations Act 2022
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
Provider Relief Fund
vaccines and pandemic response
surprise medical billing implementation
MedPAC nomination process
H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Jan. 19, 2022.
Original Filing: 301327270.xml
Lobbying Issues
ARPA-H, reconciliation
S. Con. Res. 14
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
Provider Relief Fund
vaccines and pandemic response
surprise medical billing implementation
H.R. 1319, American Rescue Plan of 2021 implementation
MedPAC nomination process
H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Oct. 18, 2021.
Original Filing: 301301898.xml
Lobbying Issues
ARPA-H, reconciliation
S. Con. Res. 14
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
Provider Relief Fund
vaccines and pandemic response
surprise medical billing implementation
H.R. 1319, American Rescue Plan of 2021 implementation
MedPAC nomination process
H.R. 3, The Lower Drug Costs Now Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
TARPLIN, DOWNS & YOUNG, LLC amended a lobbying report for representation of American Osteopathic Association in Q22021 on July 19, 2021.
Original Filing: 301281129.xml
Lobbying Issues
S. Con. Res. 5 (117)
ARPA-H
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
Provider Relief Fund
vaccines and pandemic response
surprise medical billing implementation
H.R. 1319, American Rescue Plan of 2021 implementation
MedPAC nomination process
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on July 18, 2021.
Original Filing: 301279689.xml
Lobbying Issues
S. Con. Res. 5 (117)
ARPA-H
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
Provider Relief Fund
vaccines and pandemic response
surprise medical billing implementation
H.R. 1319, American Rescue Plan of 2021
MedPAC nomination process
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on April 18, 2021.
Original Filing: 301255497.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
Provider Relief Fund
vaccines and pandemic response
surprise medical billing implementation
H.R. 1319, American Rescue Plan of 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233959.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
H.R. 8337 - Continuing Appropriations Act of 2021
H.R. 133 - Consolidated Appropriations Act, 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
H.R. 6201 - Families First Coronavirus Response Act
S. 3548 - CARES Act
H.R. 6800 - The Heroes Act
Provider Relief Fund
H.R. 133 - Consolidated Appropriations Act, 2021
vaccines and pandemic response
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
H.R. 133 - Consolidated Appropriations Act, 2021
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Oct. 17, 2020.
Original Filing: 301212373.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
H.R. 8337 - Continuing Appropriations Act of 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
H.R. 6201 - Families First Coronavirus Response Act
S. 3548 - CARES Act
H.R. 6800 - The Heroes Act
Provider Relief Fund
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on July 16, 2020.
Original Filing: 301189868.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
H.R. 6201 - Families First Coronavirus Response Act
S. 3548 - CARES Act
H.R. 6800 - The Heroes Act
Provider Relief Fund
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on April 14, 2020.
Original Filing: 301166359.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
H.R. 6201 - Families First Coronavirus Response Act
S. 3548 - CARES Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Jan. 17, 2020.
Original Filing: 301109113.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
TARPLIN, DOWNS & YOUNG, LLC amended a lobbying report for representation of American Osteopathic Association in Q32019 on Oct. 21, 2019.
Original Filing: 301075546.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068688.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on July 19, 2019.
Original Filing: 301051555.xml
Lobbying Issues
H.R. 2740 - HHS Appropriations, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations
Veterans' Health Care, Medicare physician payment reform, physician workforce
S. 1895 - Lower Health Care Costs Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Resident Physician Shortage
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on April 19, 2019.
Original Filing: 301030732.xml
Lobbying Issues
H.J.Res. 31 - Consolidated Appropriations Act, 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, surprise billing, workforce reauthorizations
Veterans' Health Care
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
MedPAC
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Jan. 18, 2019.
Original Filing: 301009513.xml
Lobbying Issues
H.R. 6157 - HHS appropriations and continuing resolution
H.R. 695 - Department of Defense Appropriations Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - SUPPORT for Patients and Communities Act
S. 3120 - HEAL Substance Use Disorders Act
S. 2680 - Opioid Crisis Response Act
Health care access and affordability, pre-exiting conditions, risk adjustment
Veterans' Health Care
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $80,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991787.xml
Lobbying Issues
H.R. 6157 - HHS appropriations and continuing resolution
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - SUPPORT for Patients and Communities Act
S. 3120 - HEAL Substance Use Disorders Act
S. 2680 - Opioid Crisis Response Act
Health care access and affordability, pre-exiting conditions, risk adjustment
Veterans' Health Care
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
osteopathic manipulative treatment
opioid alternatives
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, TARPLIN, DOWNS & YOUNG, LLC lobbied for American Osteopathic Association , earning $50,000. The report was filed on July 20, 2018.
Original Filing: 300973388.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - SUPPORT for Patients and Communities Act
S. 3120 - HEAL Substance Use Disorders Act
S. 2680 - Opioid Crisis Response Act
Health care access and affordability, pre-exiting conditions, risk adjustment
Veterans' Health Care
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare physician payment, prescription drug access and affordability, education and outreach
Graduate Medical Education
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
Tarplin, Downs & Young, LLC filed a lobbying registration on May 30, 2018 to represent American Osteopathic Association, effective May 1, 2018.
Original Filing: 300960714.xml
Issue(s) they said they’d lobby about: Healthcare access, access, quality & affordability; opioids; graduate medical education .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...